These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2049417)

  • 1. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 1.
    Lewis S; Holmes C
    Perit Dial Int; 1991; 11(1):14-21. PubMed ID: 2049417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 2. Humoral defenses.
    Holmes C; Lewis S
    Perit Dial Int; 1991; 11(2):112-7. PubMed ID: 1854866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with a high or low incidence of peritonitis.
    Holmes CJ; Lewis SL; Kubey WY; Van Epps DE
    Am J Kidney Dis; 1990 Mar; 15(3):258-64. PubMed ID: 2154926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients.
    Lin CY; Ku WL; Huang TP
    Am J Nephrol; 1990; 10(5):368-73. PubMed ID: 1964368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY; Huang TP
    Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A; Fernando RL; Varghese Z
    Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological defenses in CAPD.
    Lamperi S; Carozzi S
    Blood Purif; 1989; 7(2-3):126-43. PubMed ID: 2663033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S
    Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of peripheral and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
    Lewis SL; Kutvirt SG; Cooper CL; Bonner PN; Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S273-7. PubMed ID: 8399587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host defence in CAPD treatment: the effect of the dialysate on cell function.
    van Bronswijk H; Verbrugh HA; Heezius EC; Verkooyen RP; van der Meulen J; Verhoef J
    Contrib Nephrol; 1990; 85():67-72. PubMed ID: 2078941
    [No Abstract]   [Full Text] [Related]  

  • 11. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.
    van Bronswijk H; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):368-73. PubMed ID: 3137037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
    Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M
    Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis.
    Fieren MW; Van den Bemd GJ; Bonta IL
    Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis.
    Rubin J; Herrera GA; Collins D
    Am J Kidney Dis; 1991 Jul; 18(1):97-102. PubMed ID: 2063862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis.
    Fernandez de Castro M; Selgas R; Jimenez C; Auxiliadora Bajo M; Martinez V; Romero JR; de Alvaro F; Vara F
    Perit Dial Int; 1994; 14(3):265-70. PubMed ID: 7948240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
    Fieren MW; van den Bemd GJ; Bonta IL
    Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal macrophage and lymphocyte cytoplasmic Ca2+: effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Santoni O; Schelotto C; Caviglia PM
    Perit Dial Int; 1993; 13 Suppl 2():S286-90. PubMed ID: 8399590
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of monophosphoryl lipid A (MPLA) on peritoneal leukocyte function.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Barocci S; Cantarella S; Versace F; Salit M; Cantaluppi A
    Adv Perit Dial; 1989; 5():143-50. PubMed ID: 2577398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.